eli lilly and tirzepatide sues companies selling alternative versions of its weight loss drug FDA approval for Zepbound (tirzepatide)

Northrup, and B

Saroglitazar, a PPAR-/ agonist, at a dosage of 4 mg qd significantly improved ALT, liver fat content (LFC), insulin resistance, and atherogenic dyslipidemia in patients with MASLD/MASH (NCT03061721)

For those struggling with obesity, FDA-approved branded medications like Wegovy and Zepbound (also tirzepatide) offer a powerful tool for significant and sustained weight loss when combined with diet and exercise

Pancreatitis typically presents with severe, persistent upper abdominal pain that often radiates to the back, sometimes accompanied by fever, nausea, and an elevated heart rate

Can GLP-1 medications be used for health, not just weight loss